THE EVIDENCE BEHIND THE FOUR PLANS

Ageing, energy and fatigue: published results

Intervention evidence helps prioritise the plan. These are not package forecasts.

Ageing, energy and fatigue: published results
PLAN / STUDYAGEING MEASUREREPORTED ENERGY OR FATIGUE
Nutrition [3]
Calorie restriction, 2 years
2–3% slower DunedinPACE
Other clocks: no significant effect
Not reported in this ageing analysis
Fitness [4]
21 energy trials, n=1,226
Not assessed in this meta-analysisEnergy +0.42 SD versus controls
95% CI 0.25–0.58
Supplements [7,5]
Two different study populations
Omega-3: about 1% slower
DunedinPACE, 3 years, n=777 [7]
Vitamin D deficiency trial: fatigue
improved 72% vs 50%, 4 weeks [5]
Sleep [6]
Digital CBT-I, n=1,711
Not assessed in this trialFatigue –3.83 points vs education
at 8 weeks (95% CI –4.48 to –3.19)

Different populations, interventions and scales. Effects cannot be added or converted into tier-specific outcomes.

Sources [3–7]. The sleep result concerns CBT-I. No equivalent peptide outcome is established by these studies.

WHY MORE SUPPORT CAN MATTER

The case for structured support

2,111

adults in the US POINTER trial

The case for structured support
LIFESTYLE SUPPORTCOGNITIVE CHANGE
Structured+0.243 SD / year
Self-guided+0.213 SD / year

More contact.
More opportunities
to refine the plan.

Structured support produced a small additional cognitive benefit over two years: +0.029 SD per year (95% CI 0.008–0.050).

[11] Baker et al. JAMA, 2025

Adults aged 60–79 at risk of cognitive decline. This supports the delivery model, not a promised package result.

APPENDIX, EXAMPLE DNA REPORT

Full genotype results 1 of 2

Full genotype results 1 of 2
BIOLOGICAL AREAGENEVARIANTRESULTREPORT IMPACT
Fat absorption and metabolismADIPOQ-11391 G>AGGModerate
Fat absorption and metabolismADRB2Arg16GlyAGModerate
Fat absorption and metabolismAPOA2-256 T>CCCModerate
Fat absorption and metabolismAPOA5-1131 T>CTCLow
Fat absorption and metabolismFABP2Ala54ThrGAModerate
Fat absorption and metabolismPPARGPro12AlaCCNo impact
Fat absorption and metabolismPLIN11482 G>AGAModerate
Energy homeostasisUCP1-3826 A>GAANo impact
Energy homeostasisUCP2-866 G>AGGNo impact
Energy homeostasisUCP355 C>TCCNo impact

Anonymised third-party report example. “No impact” refers to the report’s model, not overall health risk.

APPENDIX, EXAMPLE DNA REPORT

Full genotype results 2 of 2

Full genotype results 2 of 2
BIOLOGICAL AREAGENEVARIANTRESULTREPORT IMPACT
Carbohydrate responsivenessADRB2Gln27GluCGModerate
Carbohydrate responsivenessDRD2rs1800497 C>TTCModerate
Carbohydrate responsivenessSLC2A2Thr110IleCCNo impact
Carbohydrate responsivenessTAS1R2Ile191ValGAModerate
Energy intake and feeding behaviourFTOrs9939609ATModerate
Energy intake and feeding behaviourMC4RV103ICTModerate
Energy intake and feeding behaviourTCF7L2rs7903146CCNo impact
Exercise responsivenessADRB3Trp64ArgTTNo impact
Circadian rhythmsCLOCK3111 T>CTTNo impact
InflammationTNFA-308 G>AGGNo impact

Anonymised third-party report example. “No impact” refers to the report’s model, not overall health risk.

SCIENTIFIC REFERENCES

Sources and study context

Click a reference to open the original source. Studies evaluate specific interventions, not Sovereign Health programmes.

  1. [1]

    Diabetes Prevention Program (opens in a new tab)

    Knowler et al. NEJM, 2002

    3,234 adults at high diabetes risk. Intensive lifestyle intervention reduced diabetes incidence by 58% relative to placebo over 2.8 years.

  2. [2]

    Food4Me personalised nutrition trial (opens in a new tab)

    Celis-Morales et al. Int J Epidemiol, 2017

    Six-month internet intervention. Personalised advice improved diet quality. Adding phenotype and genotype did not improve effectiveness.

  3. [3]

    CALERIE and pace of ageing (opens in a new tab)

    Waziry et al. Nature Aging, 2023

    DNA methylation analysis in 197 healthy, non-obese adults over two years. Calorie restriction slowed DunedinPACE by 2–3%. Other ageing clocks did not significantly change.

  4. [4]

    Exercise, reported energy and fatigue (opens in a new tab)

    Wender et al. Front Psychol, 2022

    Randomised-trial meta-analysis. Energy: g = 0.415, 95% CI 0.252–0.578. The energy subset included 21 trials and 1,226 participants.

  5. [5]

    Vitamin D deficiency and fatigue (opens in a new tab)

    Nowak et al. Medicine, 2016

    120 adults with fatigue and vitamin D deficiency. At four weeks, fatigue improved in 72% with vitamin D versus 50% with placebo.

  6. [6]

    Digital CBT for insomnia (opens in a new tab)

    Espie et al. JAMA Psychiatry, 2019

    1,711 adults with insomnia symptoms. Eight-week adjusted Flinders Fatigue Scale difference: –3.83 points (95% CI –4.48 to –3.19) versus sleep-hygiene education.

  7. [7]

    DO-HEALTH biological-age substudy (opens in a new tab)

    Bischoff-Ferrari et al. Nature Aging, 2025

    777 adults aged 70+ over three years. Omega-3 affected three ageing clocks. Adding vitamin D and exercise produced additive effects only on PhenoAge.

  8. [8]

    APOE genotype and Alzheimer’s odds (opens in a new tab)

    Farrer et al. JAMA, 1997

    Meta-analysis. In White clinic/autopsy samples, odds ratios versus ε3/ε3 were 3.2 for ε3/ε4 and 14.9 for ε4/ε4. Estimates vary by population.

  9. [9]

    FINGER intervention and APOE status (opens in a new tab)

    Solomon et al. JAMA Neurol, 2018

    Prespecified two-year subgroup analysis in 1,109 older adults. Cognitive benefits were not significantly different between APOE ε4 carriers and noncarriers.

  10. [10]

    Sauna and dementia associations (opens in a new tab)

    Laukkanen et al. Age Ageing, 2017

    Observational cohort of 2,315 Finnish men. Four to seven sauna sessions weekly versus one: Alzheimer’s HR 0.35 (95% CI 0.14–0.90). Not an APOE treatment trial.

  11. [11]

    US POINTER structured lifestyle trial (opens in a new tab)

    Baker et al. JAMA, 2025

    2,111 adults aged 60–79. Structured versus self-guided support improved global cognition by an additional 0.029 SD per year (95% CI 0.008–0.050).

  12. [12]

    Diet and gut microbiota (opens in a new tab)

    Wastyk et al. Cell, 2021

    A fermented-food dietary intervention increased microbial diversity and reduced a set of inflammatory markers. This does not establish the benefit of a commercial gut test.

  13. [13]

    Peptide and compounding safety context (opens in a new tab)

    US Food and Drug Administration

    FDA identifies safety concerns and limited safety data for a number of compounded peptides. Clinical suitability and local prescribing rules require individual review.

  14. [14]

    Understanding consumer genetic results (opens in a new tab)

    MedlinePlus Genetics, US National Library of Medicine

    A genetic report provides a partial health picture. Clinical history, other tests and professional interpretation remain important.

SOVEREIGN HEALTH

Your next step

Begin with a conversation about your health priorities and the level of support you need.

Book a call